IBUPROFEN PM
Generic: IBUPROFEN AND DIPHENHYDRAMINE CITRATE
KROGER COMPANYManufacturer
ORALRoute
IBUPROFENActive Substance
2022-05-31Original Approval
IBUPROFEN PM is FDA application ANDA216204, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
15,756 reports
2
PAIN
15,061 reports
3
FATIGUE
14,489 reports
4
NAUSEA
13,518 reports
5
HEADACHE
12,091 reports
6
ARTHRALGIA
10,919 reports
7
DYSPNOEA
10,528 reports
8
VOMITING
9,978 reports
9
DIARRHOEA
9,706 reports
10
RASH
9,032 reports